Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging cancer using single photon techniques.

J R Buscombe1, E Bombardieri

  • 1Nuclear Medicine, Royal Free Hospital, London NW3 2QG, UK. j.buscombe@medsch.ucl.ac.uk

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of
|July 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot scale validation campaign of gel dosimetry for pre-treatment quality assurance in stereotactic radiotherapy.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2023
Same author

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.

World journal of nuclear medicine·2019
Same author

Role of of Nuclear Medicine in the multidisciplinary management of prostate cancer.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2015
Same author

Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2015
Same author

Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).

The British journal of radiology·2015
Same author

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy.

European journal of nuclear medicine and molecular imaging·2013

Single photon emission computed tomography (SPECT) imaging remains crucial in nuclear oncology, offering cost-effective cancer diagnosis and treatment planning. Advances in SPECT/CT technology enhance lesion localization and diagnostic accuracy for improved patient management.

Area of Science:

  • Nuclear oncology
  • Medical imaging
  • Radiochemistry

Background:

  • Positron emission tomography (PET) is a leading nuclear oncology imaging modality.
  • Single photon tracers, like thallium-201 (Tl) and somatostatin analogues, are vital for visualizing many cancers.
  • Understanding cancer biology and exploiting differences between cancerous and normal tissues are key for diagnosis.

Purpose of the Study:

  • To review the scope of single photon tracers in oncology.
  • To highlight the continued importance of SPECT imaging alongside PET.
  • To discuss advancements in SPECT technology and new tracer development for cancer management.

Main Methods:

  • Review of current literature on single photon tracer applications in oncology.
  • Discussion of emerging receptor systems (gastrin, bombesin) and targeted agents (e.g., for hypoxia, angiogenesis, apoptosis).

Related Experiment Videos

  • Emphasis on the integration of SPECT/CT systems for improved image co-registration and diagnostic accuracy.

    • Main Results:

    • Single photon imaging remains essential for cancer diagnosis and treatment assessment, often at a lower cost than PET.
    • New SPECT agents can identify key cancer processes like hypoxia, angiogenesis, and apoptosis.
    • Dual-modality SPECT/CT systems significantly improve lesion localization and diagnostic confidence by fusing functional and anatomical data.

    Conclusions:

    • Single photon imaging, particularly with SPECT/CT, offers valuable, cost-effective solutions in nuclear oncology.
    • Advancements in tracers and imaging technology continue to expand the role of SPECT in cancer diagnosis and management.
    • High-quality SPECT imaging is increasingly important for preassessment in radionuclide therapy and overall clinical decision-making.